A further study revealed that the magnitude of reinvigoration of T cells with an exhausted phenotype determined in relation to pretreatment tumor burden is correlated with clinical responses in anti-PD-1-treated melanoma patients [88]. Here, PDCD1 is linked to neoplasm.